From Michelle: Biogen issues a press release regarding FDA approval of new Novartis drug, Gilenya. Basically saying-- "Our drugs (Avonex and Tysabri) are less dangerous! Stick with Biogen- You'll have less of a chance of dying!".....oh, the irony!


Stock Market Information | Stock Market Summary (NSDQ, NYSE, AMEX and more) on Boston.com
finance.boston.com
Biogen Idec is committed to improving the lives of people with multiple sclerosis (MS), and no company is doing more for these patients. There has been a desire within the MS community for an oral treatment for a long time, and the approval of Gilenya has made this a reality.